Clinical Trials and Progress With Paclitaxel in Ovarian Cancer

International Journal of Women's Health - New Zealand
doi 10.2147/ijwh.s7012
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

TGFBI Promoter Hypermethylation Correlating With Paclitaxel Chemoresistance in Ovarian Cancer

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2012English

Role of Nab-Paclitaxel in Metastatic Breast Cancer: A Meta-Analysis of Randomized Clinical Trials

Oncotarget
Oncology
2017English

Evaluation of the Efficacy of Paclitaxel With Curcumin Combination in Ovarian Cancer Cells

Oncology Letters
Cancer ResearchOncology
2016English

Emodin Sensitizes Paclitaxel-Resistant Human Ovarian Cancer Cells to Paclitaxel-Induced Apoptosis in Vitro

Oncology Reports
MedicineCancer ResearchOncology
2009English

Population Pharmacokinetc/Pharmacodynamic Modeling of Paclitaxel and Carboplatin in Ovarian Cancer

Clinical Cancer Research
Cancer ResearchOncology
2008English

Ovarian Cancer Guidelines: Treatment Progress and Controversies

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2011English

Clinical Response in Patients With Ovarian Cancer Treated With

ecancermedicalscience
Cancer ResearchOncology
2017English

A Self-Assembling Nanoparticle for Paclitaxel Delivery in Ovarian Cancer

Biomaterials
Mechanics of MaterialsBiophysicsBiomaterialsBioengineeringCompositesNanoscienceNanotechnologyCeramics
2009English

Genetic Polymorphisms and Ovarian Cancer Risk and Response to Paclitaxel/Cisplatin Chemotherapy

Hereditary Cancer in Clinical Practice
OncologyGenetics
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy